pharma · Dyslipidemia at High to Very High Cardiovascular Risk · Suspected or confirmed Gram negative infections
Menarini Asia-Pacific
A.Menarini Australia Pty Limited
Menarini Asia-Pacific clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Singapore, SG HQ
720 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Singapore, SG
- Employees
- 720
- Programs
- 2
- Drugs
- 15
- Patents
- 0
Menarini Asia-Pacific projects
2 ClinicalTrials.gov programs sponsored by Menarini Asia-Pacific.
Menarini Asia-Pacific has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Menarini Asia-Pacific have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.